The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93. - Kyle RA; Jacobus S; Friedenberg WR; Slabber CF; Rajkumar SV; Greipp PR; Kyle, Robert A; Jacobus, Susanna; Friedenberg, William R; Slabber, Coenraad Frederik; Rajkumar, S Vincent; Greipp, Philip R (Cancer (0008543X), 2009)